| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/17/2004 | CN1481846A Anti-age instant formulation |
| 03/17/2004 | CN1481845A Anti-age glue pill |
| 03/17/2004 | CN1481844A Anti-age honeydewed pill |
| 03/17/2004 | CN1481843A Anti-age tablet formulation |
| 03/17/2004 | CN1481842A Anti-age liquid formulation |
| 03/17/2004 | CN1481840A Medication for cardiac ache and preparation method |
| 03/17/2004 | CN1481834A Bear gall pill of benefiting the liver |
| 03/17/2004 | CN1481829A Healthcare food of marigold pollen |
| 03/17/2004 | CN1481828A Nourishing and healthcare medicated wine comprising Chinese caterpillar fungus and Chinese wolfberry |
| 03/17/2004 | CN1481821A Oral liquid of s snake extract |
| 03/17/2004 | CN1481812A Spray formulation of providone iodine |
| 03/17/2004 | CN1481807A Use for amylose of Chinese angelica root in preparation of liver trauma medication |
| 03/17/2004 | CN1481805A Medication for hepatitis and its preparation method |
| 03/17/2004 | CN1481785A Application of 1, 3-diphenyl-1, 3-propanedione in preparing medicine for treating hepatitis |
| 03/17/2004 | CN1142182C Macroweb bombinator antisperm polypeptide and its preparation process and use in medicine |
| 03/17/2004 | CN1142180C Giant web bombinator proteinase inhibitor and its prepn. and pharmaceutical application |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1142144C 4-phenyl pyridine derivatives |
| 03/17/2004 | CN1141970C Compound traditional Chinese medicine tea bag for curing fatty liver and hyperlipemia and its production method |
| 03/17/2004 | CN1141966C Medication for curing calculus of liver,gall and urinary tract |
| 03/17/2004 | CN1141951C Medicine for ulcer in the oral cavity |
| 03/17/2004 | CN1141949C Watermelon juice with clearing and fortifying viscera function which can live through winter and its processing method |
| 03/17/2004 | CN1141942C Health-care polypeptide product of nerve and its preparing process |
| 03/16/2004 | US6706878 Spiroazabicyclic heterocyclic compounds |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706751 Dihydroindole and tetrahydroquinoline derivatives |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706737 Inhibiting gastric acid secretion are known in the art and include a class of benzimidazole- substituted compounds, one of which is omeprazole |
| 03/16/2004 | US6706727 ethyl-4-chloro- or 4-hydroxy- Ascomycin derivatives; pimecrolimus homologues; cultivating Streptomyces hygroscopius to produce the 4-hydroxy derivative; replacement of the hydroxy with chloro under epimerization; antiinflammatory; immunosupression |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | US6706702 For therapy of neurological and psychological disorders |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706287 Microencapsulated or enteric coated composition comprising a probiotic, a prebiotic, and an ammoniaphilic urea degrading microorganism with high alkaline ph stability and high urease activity |
| 03/16/2004 | CA2331446C Biodegradable sustained-release alginate gels |
| 03/16/2004 | CA2265651C Immediate wettability water soluble film or water soluble layer for oral application |
| 03/16/2004 | CA2190847C Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020433A1 Novel crystals |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020421A1 Novel quaternary ammonium compounds |
| 03/11/2004 | WO2004019982A1 Remedy |
| 03/11/2004 | WO2004019963A1 Composition comprising crude drug extract having treating and preventing activity of hepatic disease caused by viral infection |
| 03/11/2004 | WO2004019957A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019928A1 Therapeutic agent for hepatic disease |
| 03/11/2004 | WO2004019921A2 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 03/11/2004 | WO2004019879A2 Motilide compounds |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2004000219A3 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003096977A3 Methods of treating hepatitis |
| 03/11/2004 | WO2003084342A3 Method and dietary composition for improving lipid digestibility |
| 03/11/2004 | WO2003068261A3 Means and methods for altering the motility of the gastrointestinal tract |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003057133A3 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003014316A3 Immunomodulatory compositions, formulations, and methods for use thereof |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002083074A3 Methods for the treatment of hepatic disorders |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049045 Process for the crystallization of (r)-or (s)-lansoprazole |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040048922 Allomorph of isomer Z hydrochloride of alkylaminofurane derivative |
| 03/11/2004 | US20040048917 New use of compounds as antibacterial agents |
| 03/11/2004 | US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis |
| 03/11/2004 | US20040048898 Benzimidazole compound crystal |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048896 Treating gastric acid disorders by orally administering a proton pump inhibitor and a mixture of buffers |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048881 Quinazoline derivatives with anti-tumour activity |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048862 Chemical compounds |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |